Video: Paul Chang, MD, at RSNA 2011, Calls For Quality Improvement Dashboards
CHICAGO - You can't improve what you don't measure, says Paul Chang in this video clip from RSNA 2011. He thinks radiology practices should follow other businesses and adopt business analytics and key perfromance indicators. How else can you tell if you are adding quality and improving processes?
Paul Chang, MD, gave a talk at RSNA 2011 encouraging adoption of business analytics and benchmarking tools in radiology. You can't improve what you don't measure, he pointed out. And toher business have used these tools forever.
Why not radiologists? Chang blamed a combination of "arrogance and ignorance" and says it's time to move past simple PACS and RIS to really examine what radiologists are contributing.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
